Publication Cover
Canadian Journal of Respiratory, Critical Care, and Sleep Medicine
Revue canadienne des soins respiratoires et critiques et de la médecine du sommeil
Volume 5, 2021 - Issue 2: 2020 Year in Review
223
Views
0
CrossRef citations to date
0
Altmetric
Articles

Respiratory physiology

ORCID Icon

References

  • Stanojevic S, Beaucage F, Comondore V, et al. Resumption of pulmonary function testing during the post-peak phase of the COVID-19 pandemic: A position statement from the Canadian Thoracic Society and the Canadian Society of Respiratory Therapists. Can J Respir Crit Care, Sleep Med. 2020;4(3):156–159. doi:10.1080/24745332.2020.1796211.
  • Wilson KC, Kaminsky DA, Michaud G, et al. Restoring pulmonary and sleep services as the COVID-19 pandemic lessens. From an Association of Pulmonary, Critical Care, and Sleep Division Directors and American Thoracic Society-coordinated Task ForceAnn Am Thorac Soc. 2020;17(11):1343–1351. doi:10.1513/AnnalsATS.202005-514ST.
  • Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–968. doi:10.1183/09031936.05.00035205.
  • Decrue F, Gorlanova O, Usemann J, Frey U. Lung functional development and asthma trajectories. Semin Immunopathol. 2020;42(1):17–27. doi:10.1007/s00281-020-00784-2.
  • Krishnan JK, Martinez FJ. Lung function trajectories and chronic obstructive pulmonary disease: Current understanding and knowledge gaps. Curr Opin Pulm Med. 2018;24(2):124–129. doi:10.1097/MCP.0000000000000456.
  • Ross JC, Castaldi PJ, Cho MH, et al. Longitudinal modeling of lung function trajectories in smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;198(8):1033–1042. doi:10.1164/rccm.201707-1405OC.
  • McCarthy DS, Craig DB, Cherniack RM. Intraindividual variability in maximal expiratory flow-volume and closing volume in asymptomatic subjects. Am Rev Respir Dis. 1975;112(3):407–411. doi:10.1164/arrd.1975.112.3.407.
  • Sourk RL, Nugent KM. Bronchodilator testing: Confidence intervals derived from placebo inhalations. Am Rev Respir Dis. 1983;128(1):153–157. doi:10.1164/arrd.1983.128.1.153.
  • Kory RC, Callahan R, Boren HG, Syner JC. The veterans administration-army cooperative study of pulmonary function. I. Clinical spirometry in normal men. Am J Med. 1961;30(2):243–258. doi:10.1016/0002-9343(61)90096-1.
  • Xiao D, Chen Z, Wu S, China Pulmonary Health Study Group, et al. Prevalence and risk factors of small airway dysfunction, and association with smoking, in China: findings from a national cross-sectional study. Lancet Respir Med. 2020;8(11):1081–1093. doi:10.1016/S2213-2600(20)30155-7.
  • Janson C, Malinovschi A, Amaral AFS, et al. Bronchodilator reversibility in asthma and COPD: Findings from three large population studies. Eur Respir J. 2019;54(3):1900561. doi:10.1183/13993003.00561-2019.
  • Higgins MW, Keller JB, Higgins MW, Keller JB. Predictors of mortality in the adult population of tecumseh: Respiratory symptoms, chronic respiratory disease, and ventilatory lung function. Arch Environ Health. 1970;21(3):418–424. doi:10.1080/00039896.1970.10667260.
  • SchüNemann HJ, Dorn J, Grant BJB, Winkelstein W, Trevisan M. Pulmonary function is a long-term predictor of mortality in the general population: 29-Year follow-up of the Buffalo Health Study. Chest. 2000;118(3):656–664. doi:10.1378/chest.118.3.656.
  • Weinmayr G, Schulz H, Klenk J, The ActiFE Study Group, et al. Association of lung function with overall mortality is independent of inflammatory, cardiac, and functional biomarkers in older adults: the ActiFE-study. Sci Rep. 2020;10(1):11862. doi:10.1038/s41598-020-68372-w.
  • Bikov A, Lange P, Anderson JA, et al. FEV1 is a stronger mortality predictor than FVC in patients with moderate copd and with an increased risk for cardiovascular disease. COPD. 2020;Volume 15:1135–1142. doi:10.2147/COPD.S242809.
  • Duong ML, Islam S, Rangarajan S, et al. Mortality and cardiovascular and respiratory morbidity in individuals with impaired FEV 1 (PURE): an international, community-based cohort study. Lancet Glob Heal. 2019;7(5):e613–e623. doi:10.1016/S2214-109X(19)30070-1.
  • Bui DS, Lodge CJ, Burgess JA, et al. Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life. Lancet Respir Med. 2018;6(7):535–544. doi:10.1016/S2213-2600(18)30100-0.
  • Lange P, Celli B, Agustí A, et al. Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. N Engl J Med. 2015;373(2):111–122. doi:10.1056/NEJMoa1411532.
  • Ørts LM, Bech BH, Lauritzen T, Carlsen AH, Sandbaek A, Løkke A. Lung function in adults and future burden of obstructive lung diseases in a long-term follow-up. Npj Prim Care Respir Med. 2020;30(1):1–8. doi:10.1038/s41533-020-0169-z.
  • Graham BL, Steenbruggen I, Barjaktarevic IZ, et al. Standardization of spirometry 2019 update an official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med. 2019;200(8):e70–E88. doi:10.1164/rccm.201908-1590ST.
  • Graham BL, Brusasco V, Burgos F, et al. 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J. 2017;49(1):1600016. doi:10.1183/13993003.00016-2016.
  • Das N, Verstraete K, Stanojevic S, Topalovic M, Aerts J-M, Janssens W. Deep learning algorithm helps to standardise ATS/ERS spirometric acceptability and usability criteria. Eur Respir J. 2020;56(6):2000603. doi:10.1183/13993003.00603-2020.
  • Landman ST, Dhaliwal I, MacKenzie CA, Martinu T, Steele A, Bosma KJ. Life-threatening bronchiolitis related to electronic cigarette use in a Canadian youth. CMAJ. 2019;191(48):E1321–E1331. doi:10.1503/cmaj.191402.
  • Bhattarai P, Myers S, Chia C, et al. Clinical application of Forced Oscillation Technique (FOT) in early detection of airway changes in smokers. JCM. 2020;9(9):2778. doi:10.3390/jcm9092778.
  • Cottee AM, Seccombe LM, Thamrin C, King GG, Peters MJ, Farah CS. Bronchodilator Response Assessed by the Forced Oscillation Technique Identifies Poor Asthma Control With Greater Sensitivity Than Spirometry. Chest. 2020;157(6):1435–1441. In: Vol Elsevier Inc; doi:10.1016/j.chest.2019.12.035.
  • Bell SC, Mall MA, Gutierrez H, et al. The future of cystic fibrosis care: a global perspective. Lancet Respir Med. 2020;8(1):65–124. doi:10.1016/S2213-2600(19)30337-6.
  • Saunders C, Jensen R, Robinson PD, et al. Integrating the multiple breath washout test into international multicentre trials. J Cyst Fibros. 2020;19(4):602–607. doi:10.1016/j.jcf.2019.11.006.
  • O'Neill K, Ferguson K, Cosgrove D, et al. Multiple breath washout in bronchiectasis clinical trials: is it feasible? ERJ Open Res. 2020;6(4):00363-2019–02019. doi:10.1183/23120541.00363-2019.
  • Driskel M, Horsley A, Fretwell L, Clayton N, Al-Aloul M. Lung clearance index in detection of post-transplant bronchiolitis obliterans syndrome. ERJ Open Res. 2019;5(4):00164-2019–02019. doi:10.1183/23120541.00164-2019.
  • Thompson BR, Ellis MJ, Stuart-Andrews C, et al. Early bronchiolitis obliterans syndrome shows an abnormality of perfusion not ventilation in lung transplant recipients. Respir Physiol Neurobiol. 2015;216:28–34. doi:10.1016/j.resp.2015.05.003.
  • Smith L, Horsley A, Bray J, et al. The assessment of short and long term changes in lung function in CF using 129 Xe MRI. Eur Respir J. 2020;56(6):2000441. doi:10.1183/13993003.00441-2020.
  • Smith LJ, Collier GJ, Marshall H, et al. Patterns of regional lung physiology in cystic fibrosis using ventilation magnetic resonance imaging and multiple-breath washout. Eur Respir J. 2018;52(5):1800812–1800821. doi:10.1183/13993003.00821-2018.
  • Ruppert K, Qing K, Patrie JT, Altes TA, Mugler JP. Using hyperpolarized Xenon-129 MRI to quantify early-stage lung disease in smokers. Acad Radiol. 2019;26(3):355–366. doi:10.1016/j.acra.2018.11.005.
  • Anagnostopoulou P, Latzin P, Jensen R, et al. Normative data for multiple breath washout outcomes in school-aged Caucasian children. Eur Respir J. 2020;55(4):1901302. doi:10.1183/13993003.01302-2019.
  • King GG, Bates J, Berger KI, et al. Technical standards for respiratory oscillometry. Eur Respir J. 2020;55(2):1900753. doi:10.1183/13993003.00753-2019.
  • Topalovic M, Das N, Burgel PR, et al. Artificial intelligence outperforms pulmonologists in the interpretation of pulmonary function tests. Eur Respir J. 2019;53(4):1801660. doi:10.1183/13993003.01660-2018.
  • Zhang Y, Xiong X, Dai F, et al. Curvilinearity of a maximum expiratory flow-volume curve: A useful indicator for assessing airway obstruction in children with asthma. Respir Care. 2020;65(4):427–436. doi:10.4187/respcare.07142.
  • Ioachimescu OC, Stoller JK. An alternative spirometric measurement: Area under the expiratory flow–volume curve. Annals Ats. 2020;17(5):582–588. doi:10.1513/AnnalsATS.201908-613OC.
  • Vyas DA, Eisenstein LG, Jones DS. Hidden in plain sight - Reconsidering the use of race correction in clinical algorithms. N Engl J Med. 2020;383(9):874–882. doi:10.1056/nejmms2004740.
  • Quanjer PH, Stanojevic S, Cole TJ, ERS Global Lung Function Initiative, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: The global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–1343. doi:10.1183/09031936.00080312.
  • Braun L. Race Correction and Spirometry: Why History Matters. Chest. 2020. doi:10.1016/j.chest.2020.10.046.
  • Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020;46(6):1099–1102. doi:10.1007/s00134-020-06033-2.
  • Lv D, Chen X, Wang X, et al. Pulmonary function of patients with 2019 novel coronavirus induced-pneumonia: A retrospective cohort study. Ann Palliat Med. 2020;9(5):3447–3452. doi:10.21037/apm-20-1688.
  • Komorowski M, Aberegg SK. Using applied lung physiology to understand COVID-19 patterns. Br J Anaesth. 2020;125(3):250–253. doi:10.1016/j.bja.2020.05.019.
  • Mo X, Jian W, Su Z, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020;55(6):2001217–2001215. doi:10.1183/13993003.01217-2020.
  • Hull JH, Lloyd JK, Cooper BG. Lung function testing in the COVID-19 endemic. Lancet Respir Med. 2020;8(7):666–667. doi:10.1016/S2213-2600(20)30246-0.
  • Li H, Adv S, Li H, et al. Damaged lung gas-exchange function of discharged COVID-19 patients detected by hyperpolarized 129 Xe MRI. Sci. Advs. 2021;7(1):eabc8180. doi:10.1126/sciadv.abc8180.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.